XT
HRMY icon

XTX Topco’s Harmony Biosciences HRMY Stock Holding History

XTX Topco’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$604K Sell
21,564
-11,456
-35% -$376K 0.01% 1850
2025
Q4 		$1.24M Sell
33,020
-10,447
-24% -$343K 0.03% 878
2025
Q3 		$1.2M Buy
43,467
+34,215
+370% +$1.18M 0.06% 458
2025
Q2 		$292K Sell
9,252
-15,247
-62% -$490K 0.01% 1453
2025
Q1 		$813K Buy
24,499
+17,683
+259% +$634K 0.04% 681
2024
Q4 		$235K Sell
6,816
-4,469
-40% -$154K 0.02% 1425
2024
Q3 		$451K Buy
+11,285
New +$396K 0.03% 887
2023
Q2 		– Sell
-16,928
Closed -$553K – 1586
2023
Q1 		$553K Buy
+16,928
New +$771K 0.12% 236
2022
Q4 		– Sell
-6,735
Closed -$298K – 1294
2022
Q3 		$298K Buy
+6,735
New +$329K 0.07% 507

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

XTX Topco's HRMY Position: Q1 2026 in Review

XTX Topco reduced its Harmony Biosciences (HRMY) stake by 35% in Q1 2026, selling an estimated $376K and leaving 21,564 shares worth $604K. The position accounts for 0.01% of the portfolio, ranked #1850.

XTX Topco first reported a position in HRMY in Q3 2022 and has held it in 9 quarters since. The position peaked at $1.24M in Q4 2025. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • XTX Topco held 21,564 shares of Harmony Biosciences worth $604K as of Q1 2026.
  • XTX Topco sold 11,456 Harmony Biosciences shares in Q1 2026, an estimated $376K.
  • Harmony Biosciences made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1850 holding.
  • XTX Topco first reported a position in Harmony Biosciences in Q3 2022 and has held it in 9 quarters since.
  • XTX Topco's Harmony Biosciences position peaked at $1.24M in Q4 2025.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.